ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2011

Mithramycin is a gene-selective Sp1 inhibitor that identifies a biological intersection between cancer and neurodegeneration.

Sama F Sleiman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.